Beruflich Dokumente
Kultur Dokumente
OVERVIEW
KONSEP BIOLOGI EPIDEMIOLOGI/ INSIDENSI GEJALA KLINIK DAN LABORATORIUM DIAGNOSIS PENETALAKSANAAN PROGNOSIS
INSIDENSI :
* LEULKEMIA AKUT DPT TERJADI PD SEMUA UMUR : - ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) > ANAK - ACUTE MYELOBLASTIC LEUKEMIA (AML) > DEWASA
- Early in the disease, - Abnormal blood cells can still do their work - May not have any symptoms, - gets worse slowly
- Blood cells are very abnormal. - They cannot carry out their normal work. - Number of abnormal cells increases rapidly. - Worsens quickly.
*Types leukemia are also grouped by, type of white blood cell that is affected. - lymphoid cells lymphocytic leukemia, myeloid cells myeloid
AML 31%
EPIDEMIOLOGI :
Leukemia : 4-5% kanker dari seluruh Kelompok umur. Merupakan keganasan paling sering pada anak. USA.: 3-5/100.000 penduduk per tahun Sex: : = 1,4 : 1 LMA sering pada dewasa LLA > sering pada anak ( 75-80% )
PATOGENESIS
Perubahan molekul DNA sel hemopoetik Perubahan gen normal tertentu Transformasi maligna Proliferasi klonal abnormal sel induk/ sel progenitor
DIAGNOSIS :
- GEJALA DAN
TANDA KLINIS
- LABORATORIUM - BMP (BONE MARROW PUNCTION/ BONE MARROW ASPIRATION ) - BMB (BONE MARROW BIOPTIE ).
SYMPTOMS :
When there are excessive white blood cells --> Infections When there are few red blood cells: Paleness --> Anemia When there are few platelets --> Excessive bleeding
Bone Marrow
Treatment
Chemotherapy Immunotherapy Radiation Bone marrow transplant
Research
New drugs
Cord blood and planceta
Classification of leukemias
Acute Myeloid origin Lymphoid origin
Acute Myeloid Leukemia (AML) ( M1 M7)
Chronic
Chronic Myeloid Leukemia (CML)
OBJECTIVE :
Define acute leukemia Classify leukemia Understand the pathogenesis Understand the pathophysiology Able to list down the laboratory investigations required for diagnosis Understand the basic management of leukemia patients
ACUTE LEUKAEMIA
* Define : heterogenous group of malignant disorders which is characterised by uncontrolled clonal and accumulation of blasts cells in the bone marrow and body tissues Sudden onset If left untreated is fatal within a few weeks or months
Causes :
HIGH LEVEL RADIATION/TOXIN EXPOSURE IONIZING RADIATION VIRUSES (HTLV I) UNDERLYING HEMATOLOGIC DISORDERS HEREDITARY/GENETIC CONDITIONS CHEMICALS, DRUGS MOSTLY UNKNOWN IDIOPATHIC (MOST) CANT BE CAUGHT
* Develop as a result of a genetic alteration within single cell in the bone marrow a). Epidemiological evidence : 1. Hereditary Factors - Fanconis anaemia - Downs syndrome - Ataxia telangiectasia 2. Radiation, Chemicals and Drugs 3. Virus related Leukemias - Retrovirus :- HTLV 1 & EBV b). Molecular Evidence * Oncogenes : - Gene that code for proteins involved in cell proliferation or differentiation * Tumour Suppressor Genes : - Changes within oncogene or suppressor genes are necessary to cause malignant transformation. - Oncogene can be activated by : chromosomal translocation point mutations inactivation *In general, several genes have to be altered to effect neoplastic transformation.
PATHOPHYSIOLOGY
Acute leukemia cause morbidity and mortality through : A. Deficiency in blood cell number and function B. Invasion of vital organs C. Systemic disturbances by metabolic imbalance
A.Deficiency in blood cell number or function * Infection - Most common cause of death - Due to impairment of phagocytic function and neutropenia. * Hemorrhage - Due to thrombocytopenia or 2o DIC or liver disease. * Anaemia - normochromic-normocytic - severity of anaemia reflects severity of disease - Due to ineffective erythropoiesis
B. Invasion of vital organs - vary according to subtype * Hyperleukocytosis - cause increase in blood viscosity - Predispose to microthrombi or acute bleeding - Organ invole : brain, lung, eyes - Injudicious used of packed cell transfusion precipitate hyperviscosity. * Leucostatic tumour - Rare - Blast cell lodge in vascular system forming macroscopic pseudotumour erode vessel wall cause
bleeding
METABOLIC IMBALANCE :
- Due to disease or treatment - Hyponatremia vasopressin-like subst. by myeloblast - Hypokalemia due to lysozyme release by myeloblast - Hyperuricaemia- spont lysis of leukemic blast release purines into plasma.
EPIDEMIOLOGI:
Leukemia : 4-5% kanker dari seluruh kelompok umur. Merupakan keganasan paling sering pada anak. USA.: 3-5/100.000 penduduk per tahun Sex: : = 1,4 : 1 LMA sering pada dewasa LLA > sering pada anak ( 75-80% )
Clincal manifestations :
marrow failure tissue infiltration leukostasis constitutional symptoms other (DIC)
INFILTRATION OF TISSUES/ORGANS :
Enlargement of liver, spleen, lymph nodes Gum hypertrophy Bone pain Other organs: CNS, skin, testis, any organ.
Gum hypertrophy
Patogenesis
Perubahan molekul DNA sel hemopoetik
* Klasifikasi LLA
L1 : morfologi sel relatif homogen, bentuk sel kecil, sitoplasma sedikit, nukleoli kecil/ tidak jelas L2 : morfologi sel relatif heterogen, sel besar, sitoplasma lebih banyak, nukleoli jelas L3 : seperti Limfoma Burkit,sel besar, sitoplasma biru, vakuola ()
T ALL
B ALL
ALL
nave B-lymphocytes Plasma cells T-lymphocytes
Lymphoid progenitor
AML
Hematopoietic stem cell Myeloid progenitor Neutrophils Eosinophils Basophils Monocytes Platelets
Red cells
MYELOID MATURATION:
myeloblast promyelocyte myelocyte metamyelocyte band neutrophil
MATURATION
Adapted and modified from U Va website
Pemeriksaan Laboratorium
Anemia (normokrom normositer) Hitung Leukosit: menurun/normal/meningkat hingga 200.000/mm3 Trombositopenia Darah tepi: sel blast (+), auer rods, promielosit, neutrofil agranuler, sel pseudopelger, eritroblast dalam jumlah banyak (M5) Sumsum tulang : hiperselular, sel blast (50-75%). Pada LLA aspirasi sulit (serabut retikulin ). Pada M7 khas : pansitopeni mendadak dan fibrosis sumsum tulang. Pemeriksaan faal hemostasis : DIC (M3) Leukemia otak : LP tekanan cairan otak meningkat dan mengandung sel leukemia
42
PICTURES OF BLOOD :
Platelet
White Cell Red Cell White Cell Red Cell
Platelet
Blasts
ALL L1.
ALL L2 .
ALL L3.
ALL. ..L2.
FAB. CLASSICATION OF AML. LEUKEMIA PEROKSIDASE/ SUDAN BLACK ESTERASE SPESIFIK . CAE ++ ++ +++ + +++ - ++ NON SPESIFIK ANAE, ANBE + +++ +++ - ++ - (+ FOR CLL OR T- ALL) +++ +/+++++ +++ ++ +++ +++ +++ + /+++ +/++ ++ +++ +++ -/+ +++ f
TdT.
AML M 1 M2 M3 M4 M5 M6 M7 ALL
+++ + -
+++ -
Pemasangan kateter v.sentral (Hickman), masuk vena cava superior melalui saluran bawah kulit dada. Memudahkan pemberian kemoterapi, produk darah, antibiotika, nutrisi parenteral, pengambilan sampel darah. Pencegahan mual dan muntah akibat kemoterapi: metoclopramide, benzodiazepin, antagonis reseptor 5-HT3 selektif (ondansentron,kytril,navoban,dll) Koreksi anemia: transfusi eritrosit (PRC) Perdarahan: bisa disebabkan oleh trombositopenia/ DIC. Transfusi trombosit diberikan bila hitung trom-bosit < 20.000/mm3, atau terdapat perdarahan ringan meskipun trombosit masih 20.000/mm3. Bila ter-dapat DIC perlu transfusi Fresh Frozen Plasma(FFP). Neutropenia merupakan resiko terjadinya infeksi terutama bila hitung neutrofil < 200/mm3. Pada pen-derita Leukemia Akut, neutrofil bisa mencapai 0 selama 2 minggu.
Terapi Suportif
Perdarahan: bisa disebabkan oleh trombositopenia / DIC. Transfusi trombosit diberikan bila hitung trom-bosit < 20.000/mm3, atau terdapat perdarahan ringan meskipun trombosit masih 20.000/mm3. Bila ter-dapat DIC perlu transfusi Fresh Frozen Plasma(FFP). Neutropenia merupakan resiko terjadinya infeksi terutama bila hitung neutrofil < 200/mm3. Pada pen-derita Leukemia Akut, neutrofil bisa mencapai 0 selama 2 minggu. Mikroorganisme penyebab infeksi biasanya berasal dari flora komensal, bakteri gram (+), staphylococcus /streptococcus, gram (): Pseudomonas, E-coli, Proteus, Klebsiela dan golongan an-aerob. Mikro-organisme non patogen bisa berubah menjadi patogen: Staphylococcus epidermidis. bila neutrofil 0, lesi lokal superfisial dapat segera menjadi sepsis
Virus : Herpes zooster, Herpes simplex Jamur : Candida, Aspergilosis. Protozoa: Toxoplasma gondii (bila neutropenia berlangsung lama, limfopenia, pemberian anti- biotika spektrum luas).
Pencegahan Infeksi
Isolasi penderita (reverse barriere isolation), filter udara. Sterilisasi usus: Cotrimoksasole,Neomycine, Colistine, Quinolone, Anti jamur (Fluconazole, Amphotericine B). Kultur dari urine,feses, sputum, tengorok, gusi, hidung, ujung kateter, axila, perineum. Antiseptik topikal: mandi, kumur
Kemoterapi LLA
Induksi (hari 1-33) (Oncovin,Prednisone, Adriamycine, Mtx) Konsolidasi (hari 48-153) (Mtx.,Ara-C.,Thioguanine, Asparaginase,Cyclophosphamide). Maintanance ( 2,5 3,5 tahun ) Oncovin, Prednisone, Adramycine, 6-Mercaptopurine, Mtx., Dactinomycine. Oncovin, Prednisone, BCNU, Cyclophosphamide, 6Mercaptopurine, Mtx., Dactinomycine
Kemoterapi LMA
Ara-C + Daunorubicine ( 7+3 )
54
06/08/2013